Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05227092

3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)

Led by University Hospital, Bordeaux · Updated on 2025-06-29

60

Participants Needed

1

Research Sites

143 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this study is to compare the 3D OPTIMIZED MPRAGE WMN sequence to "conventional sequences" used in spinal cord analysis. The patients will be explored at the cervical level with the conventional 2D sagittal T2 FSE, 2D sagittal STIR, 2D sagittal PSIR, 3D T1 MPRAGE sequences, and the sequence of interest 3D sagittal OPTIMIZED WMN MPRAGE and 3D axial OPTIMIZED WMN MPRAGE. At the thoracic level, with the conventional 2D sagittal T2 FSE, 2D sagittal STIR, 3D T1 MPRAGE sequences and the sequence of interest 3D sagittal OPTIMIZED WMN MPRAGE.

CONDITIONS

Official Title

3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients older than 18 years old
  • Diagnosis of Clinically Isolated Syndrome (CIS) or Relapsing-Remitting Multiple Sclerosis (RRMS)
  • Medullary symptomatology lasting less than 6 months
  • Presence or absence of an objective lesion on a subsequent MRI scan
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Pregnant or potentially pregnant women
  • Breastfeeding women
  • Contraindications to MRI
  • Diagnoses other than multiple sclerosis such as Neuro-myelitis spectrum disease or Progressive Multiple Sclerosis
  • History of spinal cord or lumbar spine surgery
  • Patients under legal protection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU de Bordeaux

Bordeaux, France

Actively Recruiting

Loading map...

Research Team

V

Vincent Dousset, MD, PhD

CONTACT

A

Amaury Ravache, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here